Healthy eating program for early to intermediate macular degeneration
Part of Eyes & vision clinical trials.
This study tests whether a remote program that helps you eat healthier can slow the progression of macular degeneration. You'll have online meetings and track your diet, and the study provides support and tools to help you make changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early or intermediate age-related macular degeneration (AMD), but no severe scarring or bleeding in the retina.
- Your current diet is less healthy than average, based on a short dietary recall.
- You have access to a computer or smartphone for online meetings (loaners are available if needed).
- You can read and understand English, as all forms and surveys are in English.
- You do not have diabetes, high blood sugar, or take certain medications for diabetes, obesity, or cholesterol.
- You have not had cancer in the past 3 years and have no other eye diseases (besides mild refractive error or cataract surgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study focuses on people age 50+ with early “wasting away” changes in the macula (central retina) called atrophic lesions. It aims to better understand how these early changes progress and how they affect vision testing, which may help improve future treatments.
This trial studies whether taking omega-3 fatty acids can slow the worsening of dry age-related macular degeneration (AMD) in people with early or intermediate disease. It may help by testing if omega-3 changes how the retina changes over time.
This study uses artificial intelligence to track changes in the eyes of people with early or intermediate age-related macular degeneration (AMD). It aims to better understand how the disease progresses and may help doctors personalize care.
This trial uses artificial intelligence to track changes in the eyes of people with advanced age-related macular degeneration (AMD) that has caused a specific type of damage (atrophy) in the retina. The goal is to see if AI can help detect when the disease gets worse, so doctors can personalize monitoring for each patient.
This study looks at how age-related macular degeneration (AMD) affects daily activities. If you have AMD and your vision is at least 4/10, you may be able to join to help researchers understand the impact on everyday life.
This study tracks how age-related macular degeneration (AMD) progresses over time and looks at factors that might affect your vision and quality of life. By participating, you'll help researchers understand more about AMD and what might predict better or worse outcomes.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.